Erratum to: A commentary on the 2015 Canadian Clinical Practice Guidelines in glutamine supplementation to parenteral nutrition.

The author would like to issue an erratum for this article [1], and would like to declare the following competing interests which were inadvertently missed in the original publication.

Competing interests

I declare that I worked as an external freelance scientific consultant for Fresenius Kabi in Chile. My work has been limited to bibliographical analysis in the metabolic field non related with clinical practice. I have not endorsed products of Fresenius Kabi company, particularly Dipeptiven.